Some people hate MSB talk too. But should be a GvHD FDA decision this week. If people don't think investors will look at other stem cell prospects if that gats a pass...well tell em' they're dreamin'.
As I have pointed out on here, the FDA had already out performed past years by July in other celular therapy approvals. The regulatory backdrop and probability pathway for ATI is much improved. I expect MSB to get approved and a halo effect to emerge all things equal.
Media thread, page-288
-
- There are more pages in this discussion • 443 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add OCC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
65.5¢ |
Change
-0.030(4.38%) |
Mkt cap ! $157.8M | |||
| Open | High | Low | Value | Volume |
| 67.0¢ | 67.0¢ | 65.5¢ | $158.2K | 238.4K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 7 | 53257 | 65.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 66.0¢ | 15502 | 4 |
View Market Depth
| Last trade - 13.17pm 13/11/2024 (20 minute delay) ? |
| OCC (ASX) Chart |